The Guidance was developed by a Panel of HCV experts in the fields of hepatology and infectious diseases, using an evidence-based review of information that is largely available to healthcare practitioners.

The process and detailed methods for developing the Guidance are detailed in Methods Table 1. Recommendations were graded according to the strength of the recommendation and quality of the supporting evidence (see Methods Table 2). Commonly used abbreviations are expanded in Methods Table 3.


Quick Links

You are using an outdated browser, please upgrade your browser or download Firefox or Chrome.